Savient Pharms Drug Patent Portfolio
Savient Pharms owns 1 orange book drug protected by 5 US patents Given below is the list of Savient Pharms's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US5872147 | Use of oxandrolone in the treatment of chronic obstructive pulmonary disease | 05 Dec, 2017 | Expired |
| US6576659 | Use of oxandrolone in the treatment of burns an other wounds | 05 Dec, 2017 | Expired |
| US6828313 | Use of oxandrolone in the treatment of burns and other wounds | 05 Dec, 2017 | Expired |
| US6090799 | Method for ameliorating muscle weakness/wasting in a patient infected with human immunodeficiency virus-type 1 | 18 Jul, 2017 | Expired |
| US6670351 | Method for ameliorating muscle weakness/wasting in a patient infected with human immunodeficiency virus-type 1 | 20 Oct, 2012 | Expired |
Latest Legal Activities on Savient Pharms's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Savient Pharms.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
|
Correspondence Address Change
Critical
| 23 Dec, 2008 | US6828313 |
|
Recordation of Patent Grant Mailed
Critical
| 07 Dec, 2004 | US6828313 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 07 Dec, 2004 | US6828313 |
|
Issue Notification Mailed
Critical
| 18 Nov, 2004 | US6828313 |
| Dispatch to FDC | 27 Oct, 2004 | US6828313 |
|
Issue Fee Payment Received
Critical
| 19 Oct, 2004 | US6828313 |
|
Issue Fee Payment Verified
Critical
| 19 Oct, 2004 | US6828313 |
| Reverse Issue Fee | 19 Oct, 2004 | US6828313 |
|
Mail Notice of Allowance
Critical
| 18 Oct, 2004 | US6828313 |
|
Notice of Allowance Data Verification Completed
Critical
| 15 Oct, 2004 | US6828313 |
|
Case Docketed to Examiner in GAU
Critical
| 01 Oct, 2004 | US6828313 |
| Date Forwarded to Examiner | 30 Aug, 2004 | US6828313 |
| Workflow incoming amendment IFW | 19 Aug, 2004 | US6828313 |
|
Response after Non-Final Action
Critical
| 19 Aug, 2004 | US6828313 |
|
Information Disclosure Statement (IDS) Filed
Critical
| 19 Aug, 2004 | US6828313 |
Savient Pharms's Family Patents
Savient Pharms Drug List
Given below is the complete list of Savient Pharms's drugs and the patents protecting them.
1. Oxandrin
Oxandrin is protected by 5 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US5872147 | Use of oxandrolone in the treatment of chronic obstructive pulmonary disease |
05 Dec, 2017
(6 years ago)
| Expired |
| US6576659 | Use of oxandrolone in the treatment of burns an other wounds |
05 Dec, 2017
(6 years ago)
| Expired |
| US6828313 | Use of oxandrolone in the treatment of burns and other wounds |
05 Dec, 2017
(6 years ago)
| Expired |
| US6090799 | Method for ameliorating muscle weakness/wasting in a patient infected with human immunodeficiency virus-type 1 |
18 Jul, 2017
(7 years ago)
| Expired |
| US6670351 | Method for ameliorating muscle weakness/wasting in a patient infected with human immunodeficiency virus-type 1 |
20 Oct, 2012
(11 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Oxandrin's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List